In the News | Charles River
   
 
 
   
   

How to Ensure the Best Chance of Success for Your Therapeutic Proteins Program
Life Science Leader – November 5, 2009

The exciting field of biotechnology-derived therapeutic proteins, or biologics, has the potential to yield important medical breakthroughs in just about every branch of medicine. However, due to the size and complexity of these unique therapeutic proteins, the process for safely overcoming regulatory hurdles and bringing a biologic to market is vastly different from the processes for any other type of pharmaceutical. This problem is compounded due to the fact that the drug development process for individual biologics also differ greatly from each other and that no clear regulatory guidance exists for each type of biologics...Read the full article.

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

Events

view all
juin 17-juin 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th Europea...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Seri...
view all
RMS Specialist Montreal, Canada

Charles River Laboratories, Inc.